0000899243-21-044658.txt : 20211115
0000899243-21-044658.hdr.sgml : 20211115
20211115185944
ACCESSION NUMBER: 0000899243-21-044658
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211115
FILED AS OF DATE: 20211115
DATE AS OF CHANGE: 20211115
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: UNITED BIOMEDICAL INC
CENTRAL INDEX KEY: 0000896839
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41058
FILM NUMBER: 211413450
BUSINESS ADDRESS:
STREET 1: 25 DAVIDS DR
CITY: HAUPPAUGE
STATE: NY
ZIP: 11788
BUSINESS PHONE: 631-273-2828
MAIL ADDRESS:
STREET 1: 25 DAVIDS DR
CITY: HAUPPAUGE
STATE: NY
ZIP: 11788
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vaxxinity, Inc.
CENTRAL INDEX KEY: 0001851657
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 862083865
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1717 MAIN STREET
STREET 2: SUITE 3388
CITY: DALLAS
STATE: TX
ZIP: 75201
BUSINESS PHONE: (254) 244-5739
MAIL ADDRESS:
STREET 1: 1717 MAIN STREET
STREET 2: SUITE 3388
CITY: DALLAS
STATE: TX
ZIP: 75201
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-11-15
0
0001851657
Vaxxinity, Inc.
VAXX
0000896839
UNITED BIOMEDICAL INC
25 DAVIDS DRIVE
HAUPPAUGE
NY
11788
0
0
1
0
Class A common stock
2021-11-15
4
C
0
247050
A
51585416
D
Class A common stock
2021-11-15
4
C
0
4212495
A
4212495
I
Held by United Biomedical Inc., Asia
Series A preferred stock
2021-11-15
4
C
0
384410
D
Class A common stock
247050
0
D
Series A preferred stock
2021-11-15
4
C
0
6554643
D
Class A common stock
4212495
0
I
Held by United Biomedical Inc., Asia
Shares of preferred stock automatically converted into shares of Class A common stock upon closing of the Issuer's initial public offering based on a conversion rate of approximately 0.643 shares of Class A common stock for each share of preferred stock.
Held by United Biomedical, Asia Inc. ("UBIA"). The Reporting Person, through a subsidiary, holds a majority equity interest in UBIA and may be deemed to be the beneficial owner of the shares held by UBIA. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by UBIA in which the Reporting Person has no pecuniary interest.
/s/ Mei Mei Hu, As Director and Officer
2021-11-15